Sugar-Sweetened Beverages and Artificially Sweetened Beverages Associated with Cardiovascular Events and Mortality

While the consumption of carbonated soft drinks has decreased in most Western countries over the last 20 years, these are still the main source of simple sugars in our diet. The World Health Organization recommends 25-50 g of simple sugars per day, a dose covered with a single can of a carbonated soft drink. For other associations, the ideal diet includes less than 450 kcal/week in sugar-sweetened beverages.

The noxious effects of the regular consumption of sugar-sweetened beverages, such as weight gain, metabolic syndrome, and type 2 diabetes, have been shown through multiple observational studies. Moreover, a high consumption of sugar-sweetened beverages has been repeatedly associated with hypertension, coronary disease, stroke, and dyslipidemia.

An excessive sugar intake has become the main risk factor for cardiometabolic mortality in young and middle-aged adults.

Artificially sweetened beverages are often advertised as a healthier alternative to sugar-sweetened beverages, and their consumption is on the rise, particularly among children.

Some associations, including the American Heart Association (AHA), have advised caution in the use of artificially sweetened beverages as a replacement for sugar-sweetened beverages in the fight against obesity, metabolic syndrome, and diabetes, given the current uncertainties surrounding their benefit and even their safety.


Read also: Mechanisms of Infarction in Coronary Arteries with Non-Significant Lesions.


Some observational studies have reported a positive association between diet drinks and the risk of stroke, dementia, myocardial infarction, and cardiovascular death. These results might be incredibly biased, seeing how higher-risk patients consume more diet drinks.

In this work, recently published in Circulation, researchers followed 37,716 men between 1986 and 2014, plus 80,647 women between 1980 and 2014. All of these subjects were free from chronic diseases at baseline.

After adjusting for multiple factors, sugar-sweetened beverages were associated with increased global mortality in all “dose” categories (<1 per month, 1–4 per month, 2–6 per week, 1 per day and >2 per day).


Read also: What is Optimal Blood Pressure?


This association was observed for both cardiovascular mortality and cancer mortality.

Artificially sweetened beverages were associated with increased mortality only in the highest consumption category and among women. The increase in global mortality was driven by an increase in cardiovascular disease, since the aforementioned beverages were not associated with an increase in cancer mortality in any cohort.

Conclusion

The consumption of sugar-sweetened beverages was positively associated with increased global mortality, which was graded with dose. The association between a high consumption of artificially sweetened beverages and mortality among women must be confirmed through further studies.

2019-12-31-CIRCULATIONAHA-118-037401

Original Title: Long-Term Consumption of Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Mortality in US Adults.

Reference: Vasanti S. Malik et al. Circulation. 2019;139:2113–2125.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which reflects in lower rates of target lesion...

Should We Withdraw Anticoagulation Before TAVR?

Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral anticoagulant (OAC) therapy. This creates a complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...